Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital:: Identification of subjects at high risk of mortality

被引:58
作者
van Langevelde, P
Joop, K
van Loon, J
Frölich, M
Groeneveld, PHP
Westendorp, RGJ
van Dissel, JT
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Chem, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
关键词
D O I
10.1086/317480
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We prospectively examined 464 febrile patients (median age, 61 years) for predictors of in-hospital death, by use of univariate and multivariate logistic regression using clinical data (age, underlying disease, duration of fever, chills, and shock on admission) and plasma endotoxin, TNF-alpha, IL-6, IL-10, and procalcitonin levels. The mortality rate was 4.6-fold higher (95% confidence interval [CI], 1.8-12) in 31 patients with shock on admission, 7 of whom died; the strongest association with mortality was the endotoxin concentration (relative risk, 13.7; 95% CI, 1.4-136), which predicted 5 of the deaths with a 5% false-positive rate. For 433 patients without shock on admission, mortality (26 deaths) was associated with age and underlying disease: clinical data predicted 30% of the deaths, whereas IL-6 and procalcitonin levels identified an extra 10% with a 5% false- positive rate. When febrile patients are screened on hospital admission to identify those with a high risk for mortality, clinical judgment on the basis of age, underlying disease, and recent history outweighs the predictive value of endotoxin, cytokine, and procalcitonin levels. Only in patients who present with shock will measurement of endotoxin levels help predict those who will likely die at the cost of few false- positive results.
引用
收藏
页码:1343 / 1348
页数:6
相关论文
共 29 条
[1]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]   HOW BAD ARE BACTEREMIA AND SEPSIS - OUTCOMES IN A COHORT WITH SUSPECTED BACTEREMIA [J].
BATES, DW ;
PRUESS, KE ;
LEE, TH .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (06) :593-598
[3]   BACTERIAL-ENDOTOXIN AND CURRENT CONCEPTS IN THE DIAGNOSIS AND TREATMENT OF ENDOTOXAEMIA [J].
BAYSTON, KF ;
COHEN, J .
JOURNAL OF MEDICAL MICROBIOLOGY, 1990, 31 (02) :73-83
[4]   Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J].
Bone, RC .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (08) :680-687
[5]   Prediction of microbial infection and mortality in medical patients with fever:: Plasma procalcitonin, neutrophilic elastase-α1-antitrypsin, and lactoferrin compared with clinical variables [J].
Bossink, AWJ ;
Groeneveld, ABJ ;
Thijs, LG .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :398-407
[6]   ENDOTOXEMIA IN HUMAN SEPTIC SHOCK [J].
DANNER, RL ;
ELIN, RJ ;
HOSSEINI, JM ;
WESLEY, RA ;
REILLY, JM ;
PARILLO, JE .
CHEST, 1991, 99 (01) :169-175
[7]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613
[8]   PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS [J].
DOFFERHOFF, ASM ;
BOM, VJJ ;
DEVRIESHOSPERS, HG ;
VANINGEN, J ;
VANDERMEER, J ;
HAZENBERG, BPC ;
MULDER, POM ;
WEITS, J .
CRITICAL CARE MEDICINE, 1992, 20 (02) :185-192
[9]   Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein [J].
Fisher, CJ ;
Agosti, JM ;
Opal, SM ;
Lowry, SF ;
Balk, RA ;
Sadoff, JC ;
Abraham, E ;
Schein, RMH ;
Benjamin, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1697-1702
[10]   NATURAL CYTOKINE ANTAGONISTS AND ENDOGENOUS ANTIENDOTOXIN CORE ANTIBODIES IN SEPSIS SYNDROME [J].
GOLDIE, AS ;
FEARON, KCH ;
ROSS, JA ;
BARCLAY, GR ;
JACKSON, RE ;
GRANT, IS ;
RAMSAY, G ;
BLYTH, AS ;
HOWIE, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (02) :172-177